Fusion Antibodies Plc

(LSE) FAB

Current Price£0.13

Market Cap£15.02M

Since IPO (2017)-90%

5 Year-91%

1 Year+80%

1 Month-20%

Fusion Antibodies Plc Financials at a Glance

Market Cap

£15.02M

Revenue (TTM)

£3.40M

Net Income (TTM)

-£3.09M

EPS (TTM)

-£0.01

P/E Ratio

-8.33

Dividend

£0.00

Beta (Volatility)

-0.13 (Low)

Dividend

£0.00

Beta (Volatility)

-0.13 (Low)

Price

£0.13

Volume

253,146

Open

£0.12

Price

£0.13

Volume

253,146

Open

£0.12

Previous Close

£0.12

Daily Range

£0.12 - £0.13

52-Week Range

£0.06 - £0.21

Estimated Earnings Date

Sep 3, 2026

Dividend

£0.00

Beta (Volatility)

-0.13 (Low)

Price

£0.13

Volume

253,146

Open

£0.12

Previous Close

£0.12

Daily Range

£0.12 - £0.13

52-Week Range

£0.06 - £0.21

Estimated Earnings Date

Sep 3, 2026

FAB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fusion Antibodies Plc

Industry

Life Sciences Tools and Services

Sector

Health Care

CEO

Adrian Kinkaid, PhD

Website

www.fusionantibodies.com

Headquarters

Belfast, BT17 0QL, GB

FAB Financials

Key Financial Metrics (TTM)

Gross Margin

18%

Operating Margin

-1%

Net Income Margin

-92%

Return on Equity

-164%

Return on Capital

-2%

Return on Assets

-81%

Earnings Yield

-12.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£15.02M

Shares Outstanding

125.16M

Volume

253.15K

Avg. Volume

469.11K

Financials (TTM)

Gross Profit

£430.00K

Operating Income

-£1.78M

EBITDA

-£1.62M

Operating Cash Flow

-£1.36M

Capital Expenditure

-£10.00K

Free Cash Flow

-£1.37M

Cash & ST Invst.

£359.00K

Total Debt

£20.00K

Fusion Antibodies Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

£838.00K

+54.9%

Gross Profit

£185.00K

+188.5%

Gross Margin

22.08%

N/A

Market Cap

£15.02M

N/A

Market Cap/Employee

£556.25K

N/A

Employees

N/A

Net Income

-£512.00K

+62.3%

EBITDA

-£476.00K

+63.2%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Total Cash

£252.00K

-48.3%

Total Debt

£671.00K

+1327.7%

Accounts Receivable

£868.00K

+8.9%

Inventory

£272.00K

-48.1%

Long Term Debt

£566.00K

+1786.7%

Short Term Debt

£105.00K

+208.8%

Return on Assets

-80.96%

N/A

Return on Invested Capital

-1.82%

N/A

Free Cash Flow

-£635.00K

+53.0%

Operating Cash Flow

-£575.00K

+57.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SAR.LSareum Holdings plc

SAR.LSareum Holdings plc£0.23-0.89%

IHC.LInspiration Healthcare Group plc

IHC.LInspiration Healthcare Group plc£0.25-5.28%

ABDX.LAbingdon Health Plc

ABDX.LAbingdon Health Plc£0.12-2.09%

COG.LCambridge Cognition Holdings Plc

COG.LCambridge Cognition Holdings Plc£0.35-2.81%

IXI.LIXICO plc

IXI.LIXICO plc£0.08-5.14%

FUM.LFutura Medical plc

FUM.LFutura Medical plc£0.01-1.13%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.98-0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.35+0.06%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$79.93-0.06%

INTCIntel

INTCIntel$117.05-0.08%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.45-0.03%

NIONio

NIONio$5.01-0.04%

ONDSOndas

ONDSOndas$9.21-0.03%

Questions About FAB

What is the current price of Fusion Antibodies Plc?

Fusion Antibodies Plc is trading at £0.13 per share.

What is the 52-week range for Fusion Antibodies Plc?

Over the past 52 weeks, Fusion Antibodies Plc has traded between £0.06 and £0.21.

How much debt does Fusion Antibodies Plc have?

As of the most recent reporting period, Fusion Antibodies Plc reported total debt of £20.00K.

How much cash does Fusion Antibodies Plc have on hand?

Fusion Antibodies Plc reported £359.00K in cash and cash equivalents in its most recent financial results.

What is Fusion Antibodies Plc’s dividend yield?

Fusion Antibodies Plc does not currently have a dividend yield.

Fusion Antibodies Plc

Fusion Antibodies Plc Financials at a Glance

FAB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Fusion Antibodies Plc

FAB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Fusion Antibodies Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About FAB

What is the current price of Fusion Antibodies Plc?

What is the 52-week range for Fusion Antibodies Plc?

How much debt does Fusion Antibodies Plc have?

How much cash does Fusion Antibodies Plc have on hand?

What is Fusion Antibodies Plc’s dividend yield?

Premium Investing Services